Skip to main content

Table 1 Baseline Characteristics of 218 patients undergoing elective CABG

From: Clinically inapparent right heart dysfunction is associated with reduced myofilament force development in coronary artery disease

Characteristics Total
218 (100%)
Group 1
n:178 (82%)
Group 2
n: 40 (18%)
P value
Age (y, mean ± SD 67.6 ± 9.4 67.1 ± 9.5 70.0 ± 8.5 0.079
Female (n,%) 31 (14.2) 24 (13.5) 7(17.5) 0.465
Height (cm, mean ± SD) 172.0 ± 7.4 172.0 ± 7.5 172.0 ± 6.8 0.855
Weight (kg, mean ± SD) 87.5 ± 15.8 87.3 ± 16.2 88.3 ± 14.3 0.721
EuroScore II (mean ± SD) 1.6 ± 1.2 1.4 ± 1.1 2.2 ± 1.6  < 0.0001
Diabetes Mellitus (n,%) 82 (37.6) 60 (33.7) 22 (55.0) 0.018
Hypertension (n,%) 188 (86.2) 155 (87.1) 33 (82.5) 0.450
Atrial fibrillation (n,%) 45 (20.7) 28 (15.8) 17 (42.5)  < 0.0001
HbA1c (%, mean ± SD) 6.2 ± 1.0 6.1 ± 1.0 6.5 ± 1.2 0.020
NTPro-BNP (pg/mL, mean ± SD) 964.8 ± 2879.0 853.2 ± 2988.4 1461.3 ± 2257.4 0.129
Creatinine (mg/dL, mean ± SD) 1.2 ± 0.7 1.1 ± 0.8 1.2 ± 0.4 0.726
GFR (ml/min/1.73 m2, mean ± SD) 74.8 ± 23.1 76.7 ± 23.8 66.7 ± 17.6 0.013
Albumin (g/dl, mean ± SD) 4.2 ± 0.5 4.3 ± 0.5 4.1 ± 0.4 0.036
Galectin (ng/dL, mean ± SD) 10.7 ± 5.4 10.6 ± 5.7 10.9 ± 4.3 0.842
TGFβ1 (pg/mL, mean ± SD) 29,570.6 ± 68,503.3 30,876.8 ± 75,129.3 23,757.9 ± 21,591.2 0.633
N Acyl-SDMA (µmol/l, mean ± SD) 0.69 ± 0.32 0.69 ± 0.34 0.73 ± 0.22 0.318
Arginin (µmol/l, mean ± SD) 92.9 ± 31.5 92.4 ± 31.6 94.8 ± 31.0 0.363
ADMA (µmol/l, mean ± SD) 0.66 ± 0.15 0.65 ± 0.15 0.70 ± 0.13 0.046
Pentraxin-3 (pg/dl, mean ± SD) 2807.4 ± 1329.2 2681.0 ± 1353.4 3370.5 ± 1068.4 0.004
RA area (cm2 mean ± SD) 15.9 ± 4.3 15.7 ± 3.8 16.5 ± 5.8 0.089
sPAP, mmHg 27.9 ± 8.5 27.4 ± 8.1 30.3 ± 10.1 0.204
LA area (cm2 mean ± SD) 20.4 ± 5.3 19.9 ± 5.0 22.4 ± 6.0 0.005
TAPSE 23.0 ± 4.0 24.3 ± 3.1 17.3 ± 1.7  < 0.0001
LVEF (%, mean ± SD) 53.7 ± 9.8 54.6 ± 9.3 49.7 ± 11.2 0.008
  1. FEV1 forced expiratory volume, CRP C-reactive protein, HbA1c glycated haemoglobin (HbA1c), NTPro-BNP N-terminal pro brain natriuretric peptid, GFR glomerular filtration rate, TGF ß-1 Transforming Growth Factor ß, IL-6 Interleukin-6, N Acyl-SDMA Symmetric Dimethylarginine, ADMA Asymmetric Dimethylarginine, RA right atrial, sPAP Systolic pulmonary artery pressure, LA left atrial, LVEF Left ventricular ejection fraction